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It is well known that during the acute phase of certain viral infections in man, such as 
measles (1) and influenza (2), a marked degree of  immunological unresponsiveness exists, 
particularly m  cell-mediated immunity. Recent studies on effects of viruses on in vitro 
responses of lymphocytes to antigens and mitogens strengthen the view that viruses can 
influence  lymphocyte functions and  indicate  that  specific  viruses  may affect selected 
classes of lymphoid cells such as T cells (3, 4), monocytes (5, 6), or B cells (7-9) (reviewed 
in references 10-13). These findings suggest that it might be possible,  by appropriate 
choice of virus and experimental conditions, to harness the immunosuppressive capacity 
of viruses in an effort to develop a  selective strategy for diminishing specific  immune 
responses found to be clinically harmful. One such untoward response, the graft-vs.-host 
reaction, is reported to occur in 70% of recipients of human bone marrow transplants, and 
is a serious impediment to effective clinical treatment of immunodeficiency syndromes, 
aplastic anemias, and leukemias (14). 
The present  work represents  an  attempt  to suppress  graft-vs.-host reactions m  an 
experimental model using viruses  The basis for this approach derives from the observa- 
tions that while resting lymphocytes are not permissive for a var:ety of RNA viruses, 
activated lymphocytes are capable of  replicating viruses and may be killed by them in the 
process.  This  serves  as  the  basis  for a  virus  plaque  assay for enumerating antigen- 
sensitive lymphocytes, by infecting lymphocytes stimulated by a variety of antigens or 
m:togens and determining the number of cells capable of preducmg infectious centers 
(15)  The virus chosen for the studies is vesicular stomatitis virus (VSV), 1 a  relatively 
nonpathogenic agent for man although mice are extremely susceptible to it. In previous 
:n vitro studies it has been demonstrated that production of vesicular stomatitis wrus 
occurred selectively in activated T lymphocytes rather than activated B lymphocytes in 
mouse and m man (3,  16). 
More recent studies indicate that resting primary lymphocytes in fact may be 
infected by VSV,  although they are unable to permit replication of the virus. 
When  such  infected  cells  are  subsequently  stimulated,  the  virus  is  somehow 
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activated leading to death of the stimulated cell. This has resulted, for example, 
in a greater than 99% suppression of thymidine incorporation by lymphocytes 
cultured with allogeneic  mitomycin  C-treated cells in mixed lymphocyte  cul- 
tures. The precise requirements for establishing a latent or persistent infection 
by VSV in primary lymphocytes remain to be established.  Nevertheless these 
observations  suggested  the  possibility  that  histoincompatible  lymphoid  cells 
might be infected with VSV, transferred into allogeneic hosts such that activa- 
tion of the infected T  lymphocytes in the course of initiating a  graft-vs.-host 
(GVH) reaction might result in the selective destruction of the responding cells. 
The present studies are aimed at testing the possibility that such a strategy may 
diminish GVH reactions in the mouse. 
Materials and Methods 
Mice and V~rus.  Young adult male A, C57L,  and their F~ hybrids, LAF1 mice were obtained 
from  The  Jackson  Laboratory,  Bar  Harbor,  Maine.  The  stock  of VSV,  Indiana  strain,  was 
prepared in secondary chick embryo cells as described (17). The titer was 108 plaque-forming  units 
(PFU)/ml as titrated on mouse L cells 
Inductmn of GVH Reaction.  Peripheral lymph nodes (LN; i.e. axillary, mesentemc, and in- 
guinal) were obtained from young adult A, C57L, or LAFI mice  Cell suspensions were prepared in 
Hanks' balanced salt solution (HBSS) and washed. 5 x  10  e LN cells were rejected intravenously 
into LAF~  mice  1 day  after or on  the day  of 950  R  whole body ~/-irradiation  (1sTcs  ~,-source, 
Gammator M; Radiation International, Parsippany, N. J.). In some experiments the parental cells 
(107/ml) were incubated before injection with VSV (2-2.5  x  108 PFU/ml) for 2 h at 37°C in HBSS 
containing 10%  fetal  calf serum.  The  cells were then  washed three times with  or without a 
subsequent addlhon of 0 02 ml guinea pig anh-VSV, an amount sufficient to neutralize all input 
virus (serum titer >  1.10,000).  In other experiments, 108 PFU of VSV were injected directly into 
the recipient mice at various times after the injection of  5 × 10  e parental LN cells. Preincubation of 
parental cells with mitomycin C (obtained through the courtesy of  the Drug Development Branch, 
Division of Cancer Treatment,  National  Cancer Institute,  Bethesda,  Md.)  was performed by 
incubation of 107 cells/ml with 100  ~g mitomycin (Mit.)/ml for 30 rain at 37°C followed by three 
washings of the cells. For some experiments, it was necessary to Incubate LN cells with anti-Thy 
1.2  before injection.  Anti-Thy  1.2  was  prepared as  described (18),  and  the  conditions of the 
incubation were: 3.3 × 106 cells/ml, antl-Thy 1.2, 1/60; and rabbit complement (C), 1/45; 45 minutes 
at 37°C. 
GVH Assay  A modification (19) of the method of Sprent and Miller (20) was used as described. 
All  mice  received an  intraperltoneal  injection  of 25  ~C1  ZH-thymidine  (SliT;  0.36  Ci/mmol; 
Schwarz/Mann Div., Becton, Dickinson & Co, Orangeburg, N. Y.) 2 h before death, on days 3 and 
4 after parental cell injection  Mice were killed and their spleens removed. Individual spleens were 
quickly teased m  ice-cold phosphate-buffered saline (PBS), pH 7.2,  placed m  tubes, and centri- 
fuged at 1,200 rpm at 4°C for 10 mln. The cells were resuspended and incubated for 2-5 min at 37°C 
in Tris-buffered lsotomc ammonium chloride as described (19, 21)  After two addihonal washings 
m  PBS the cells were resuspended m  2 ml of 10% TCA and left for 18 h  at 4°C.  The centrifuged 
precipitates of each tube were dissolved in i  ml of Nuclear-Chicago Solubilizer (NCS; Amersham/ 
Searle Corp, Arlington Heights, Ill.) and transferred to scintillation vials containing 10 ml of a 
toluene  base  1,4-bis[2-(5-phenyloxazolyl)]benzene-scmtlltation fluid.  Radioactivity  was  deter- 
mined by B-counting m  a Packard series 3003 Tri-Carb liquid scintillation spectrometer (Packard 
Instrument Co., Inc, Downers Grove, Ill.). 
Fate of Labeled  Cells.  Parental LN cells (5 × 107/ml) were labeled with 5~Cr (sodium chromate 
solution; Amersham/Searle Corp.) at 100 ~C1/ml for 45 rain at 37°C in HBSS containing 5% fetal 
calf serum. After washing the cells three times, a  portion of the cell preparation was incubated 
with VSV as above. 107 cells containing 3.2-5.9  ×  105 cpm were then injected intravenously into 
LAF~ mice irradiated on the previous day with 950 R whole body ~/-irradiation. On days 1 and 3 
postlnjection, recipients were exsanguinated and portions of peripheral blood, spleen, hver, lung, 
and peripheral LN were excised and weighed. 5~Cr-containing cells and tissues were counted in a 668  VIRAL  IMMUNOSUPPRESSION  OF  THE  GRAFT-VS.-HOST  REACTION 
TABLE  I 
Effect of VSV Injection on Parental LN Prohferation In F1 Spleen 
Cells in-  VSV in- 
jected*  jected* 
Geometric mean cpm/recipient spleen .X  SE (n)§ 
Exp.  1  Exp.  2  Exp  3 
Parental LN  -  55,723 X. 1.05 (5) 
7 
F~ LN  -  959 ×.  1.73  (5) 
Parental LN  Day 0  2,668 .X  2.10 (5) 
Parental LN  Day 1  10,240  ×.  1 07 (5) 
X 
Parental LN  Day 2  8,817 -  1.27 (5) 
51,779 x.  1.25 (5)  11,474  ×.  1 21 (6) 
_ 
.3,669.  x  1.28 (5)  918 X  1 72 (5) 
3,362 .X  1.31  (6)  887 ~  1.50 (8) 
* 5 ×  10  e LN cells injected per recipient. Parental LN in exp  1 were from strain A, in exps. 2 and 3 
from strata C57L. 
1 25 ×  l0  s PFU of VSV injected intravenously per recipient. 
§ Groups of five to eight mice were assayed 3 days after LN cell rejection  They  w~re rejected 
intraperltoneally with 25 gC1 3HT and killed 2 h  later. 
Nuclear-Chmago  Ultrascaler II T-counter without prior solubilizatlon  (Nuclear-Chicago  Corp, 
Des Plaines, Ill.) 
Results 
Inhibition  of GVH Reactivity  of Parental  Cells  by  VSV.  Irradiated  LAF~ 
mice were injected intravenously with 5 ×  106 syngeneic or parental LN cells. 3 
days after cell injection, a marked DNA synthetic response was observed in the 
spleens of mice injected with parental cells, much higher than after injection of 
syngeneic cells (Table I). Previous studies have shown, in fact, that syngeneic 
cells do not usually cause a  significant increase of 3HT incorporation over that 
observed in uninjected control mice and that treatment of parental LN cells with 
anti-Thy 1.2 plus C brings the level of 3HT incorporation down to that seen with 
syngeneic cells  (19).  Treatment  of parental  cells with  Mit.,  that  is known to 
inhibit DNA synthesis (22), also prevents the splenic proliferative response (19). 
When recipients of 5 ×  106 A (exp. 1, Table I) or C57L (exps. 2 and 3, Table I) 
were simultaneously injected with  1.25  ×  106 PFU of VSV intravenously,  the 
resulting GVH activity as measured by ZHT incorporation on day 3 was virtually 
completely inhibited. Recipients injected with VSV 1 or 2 days after parental cell 
injection  still  showed  a  much  reduced  response,  even  though  the  assay was 
performed on day 3.  Since  previous studies  clearly showed that  a  detectable 
proliferative  response  is  present  on  day  2  (19)  this  indicates  that  the  virus 
eradicated  an  already initiated  response.  Thus,  injection  of VSV inhibits  the 
GVH reaction as detected by the spleen assay. 
Because preinfection of lymphocytes was able to block subsequent prolifera- 
tion in mixed lymphocyte cultures (reference 13 and unpublished observations), 
we attempted to block the GVH reaction by infecting the parental  LN cells in 
vitro  before transferring  them  to  F~  recipients.  The  cells  were  infected  at  a 
multiplicity of infection (mot) of 20-25 for 2 h  at 37°C and washed three times 
before injection.  Such preinfected  cells failed to  generate  GVH parental  cell ROMANOI  NOWAKOWSKI,  BLOOM,  AND  THORBECKE  669 
TABLE II 
Effect of VSV Pre~nfectmn on Parental LN Proliferation  in FI Spleen 
Cells l]lfK~t  ed * 
Treat- 
ment 
VSV mcu- 
wxth 
batmn$ 
anti- 
VSV§ 
Geometric mean cpm per spleen  SE (n) 
Exp  4  Exp  5  Exp  6  Exp  7 
Parental LN  -  -  13,091 X1 45 13)  55,723 X1 05 (5)  51,779 _'X1 25 (5)  71,979 E1 24 (5) 
F, LN  -  -  7,542_X  1 45 (3)  959  X 1 73 (5)  3,669 X  1 28 (5)  447  ~ 1 91 (6) 
-  T 
Parental LN  +  1,004 X  1 64 (4)  2,554 X. 1 34 (5)  7,657 X.  1 31 (5) 
Parental LN  +  +  3,076 X 1 72 (6)  8,639 X 1 35 (6)  8,418  X 1 32 (5) 
F~ bone marrow  -  16,964 ._X 1 20 (9)  35,426 X. 1 31 (6) 
F, bone marrow  +  -  14,434  ×_. 1 10 (6)  28,660 ~  1 09 (4) 
* 5 ×  10  s LN cells or 107 bone marrow cells rejected  per recipient  Spleens assayed on day 3 (exps  4, 5, and 6) or day 4 (exp  7) after cell 
rejection 
Cells were incubated with VSV (mo120-25) for 2 h at 37°C LN cells but not bone marrow cells were washed three txmes before mjectxon 
§ After VSV incubation and one wash cells were incubated at 37°C for 1 h with 1/200~mmea pig antl-VSV  They were then washed twice and 
lr~ected  into reclptents at a dose of 5 ×  10  s LN cells per recipient 
proliferative  activity  (Table II).  The degree of inhibition  in exps.  4,  5,  and  6 
actually amounted to 92, 96, and 85%, respectively. It could be argued that free 
virus particles were in the injected cell suspensions despite the extensive wash- 
ing of the cells and that it was this free virus rather than lymphocyte-associated 
virus that was inhibiting the GVH. To eliminate free infectious virus particles 
in the inoculum the cells were incubated for an additional h  at 4°C with 1/200 
guinea pig anti-VSV  serum,  a  concentration  sufficient to neutralize  all  input 
virus particles. After cells so treated were injected into recipients, the GVH was 
still markedly suppressed (76% in exp. 4,  83% in exp. 6, and 89% in exp. 7). 
Specificity  of VSV Immunosuppression.  It has been shown that  VSV can 
inhibit  lymphocyte  activation  induced  in  vitro  by concanavalin  A  or by the 
mixed lymphocyte reaction,  but not the one induced by lipopolysaccharide (3), 
suggesting  a  predilection  of VSV for T  cells.  To study further  this  apparent 
inability of VSV to act on non-T cells, F1 bone marrow cells (107 per recipient), 
with or without preincubation with VSV, were injected into lethally irradiated 
syngeneic recipients  and the degree of proliferation  in the spleen measured 3 
days after cell injection. In neither exp. 4 nor exp. 5 (Table II) was a significant 
reduction in proliferation seen after incubation with the virus (Student's t test: 
0.1 <P  <0.2inexp.  4and0.5<P  <0.6inexp.  5). 
It  was  found  previously that  in  GVH reactions  intravenous  injection  of a 
mixture  of mitomycin C-treated parental  LN and anti-Thy  1.2-treated  F1 LN 
gave  a  good proliferative  response  while  neither  cell  type alone  synthesized 
DNA in appreciable amounts  (19). This phenomenon is again demonstrated in 
Table III. While neither 5 ×  l0  s syngeneic LN, whether anti-Thy 1.2-treated or 
not,  nor  5  ×  10  e Mit.-treated  parental  LN injected  alone  resulted  in  a  high 
incorporation of 3HT by day 3, the simultaneous injection of both cell types gave 
a  much higher response  (approximately 35 and 59% of the response seen with 
untreated parental  cells). As was also previously determined,  the LAF1 non-T 
cells made up the bulk of this syngeneic LN proliferation (19). It should be noted 670  VIRAL  IMMUNOSUPPRESSION  OF  THE  GRAFT-VS.-HOST  REACTION 
TABLE  III 
Relative Insensitivity to VSV of Syngeneic B-Cell Proliferation zn GVH 
Cells Injected* 
Geometric mean cpm/recipient spleen  SE (n)$ 
Exp  8  Exp. 9 
F, LN  1,425  .x_ 1 36 (5)  918 .x  1 74 (6) 
Parental M1t  LN§ 
Antl-Thy 1 2-treatedll parental LN 
Parental LN 
Parental VSV-LN¶ 
Parental  Mit.  LN  +  anti-Thy  1.2- 
treated F, LN 
Parental  Mit.  LN  +  anti-Thy  1.2- 
treated F, LN incubated with VSV 
Parental Mit. LN incubated with VSV 
+  anti-Thy 1.2-treated F, LN 
474 
916 
24,158 
721 
9,325 
4,379 
1.26 (5) 
x_.  1.26 (5) 
_.x  1.45 (5) 
._x  1 59 (6) 
x._  1.26 (7) 
_x.  1 95 (5) 
ND 
689 x.  1.29 (6) 
626 .x  1.20  (6) 
11,474  _x  1.20 (6) 
549 .x  1.59 (6) 
6,533  _.x  1 20 (6) 
3,812  _.  1.38 (6) 
867 x.  1.26 (6) 
* 5  X  i06 LN  cells injected per recipient  Where  mixtures of different cell  populations were 
concerned, 5 x 106 LN cells  of  each cell  type were injected. 
Mice were assayed on day 3. They were killed 2 h after  an intraperItoneal injection  of 25 pCl 
3HT 
§ M1t  LN, lymph node cells  treated wlth 100 f~g/ml Mit. for 30 rain at 37°C. 
II  LN  cells  were treated with 1/60 anti-Thy 1.2 and 1/45  rabbit C  for 45 rain at 37°C at a final 
concentration of  3.3 x 106 cells/ml 
¶ Cells incubated for  2 h at 37°C at a concentratlon of  107/ml with VSV at a concentration of  2.5 × 
108 PFU/ml 
that incubation  of the anti-Thy 1.2-treated  F, LN cells  with VSV  followed by 
washing still  allowed them to  be recruited by Mit.-treated parental cells  (exps. 8 
and 9,  Table III)  although the  3HT incorporation was about half  the amount seen 
without VSV incubation of  the F, cells.  This suggested that the non-T elements 
were  relatively insensitive to the action of VSV,  and  certainly much  less 
sensitive than the parental T cells  since  their activity  was totally  abolished by 
the same amount of  virus (3-4% of  the response remaining). It  was of  additional 
interest to note that Mit.-treated parental LN  cells  which had been preincu- 
bated with VSV  were no longer capable of  recruiting F, B cells  into  prolifera- 
tion. It appears that the VSV  incubation has an even more drastic inhibitory 
effect  on the T cells  than Mit. treatment. 
Effect of Preincubation with VSV on the Subsequent Homing of Parental LN 
Cells  in F, Hosts.  A possible criticism of the conclusion that VSV suppresses 
GVH is that the virus might alter the homing pattern and organ distribution of 
parental LN cells, thereby reducing the number of parental cells in the spleens 
of recipients  (23).  Thus,  the  low 3HT incorporation  in the  recipients'  spleens 
could be due to a failure of parental LN to home to spleen instead of an actual 
destruction  of reactive  allogeneic  T  blasts by VSV.  To differentiate  between 
these possibilities, experiments were performed to examine the effect, if any, of 
preincubation  with  VSV on the fate of injected cells.  Parental  LN cells were ROMANO,  NOWAKOWSKI,  BLOOM,  AND  THORBECKE  671 
TABLE  IV 
Effect of VSV Incubation on the Organ Distribution of 51Cr-Labeled  Parental LN Cells* 
Day  % of injected cpm/100 MG Tissue 
VSV  after 
treat-  m- 
ment$  jec-  Spleen  LN  Liver  Lung  Blood§ 
hon 
-  1  31.04  _+  3.211  2.50  -+  1.1  3.12  _*  0.3  2.78  _+  0.6  5.79  _+  0.3 
+  1  42.74  _+  1.3  1.53  -+ 0.6  6.60  _*  0.8  1.62  -+ 0.2  11.23  _+  0.8 
-  3  32.25  -+ 2.6  1.97  _+  0.7  4.04  _+  0.5  1.98  -+ 0.5  4.28  _+  0.8 
+  3  38.42  _+  3.3  3.18  _+  0.7  5.63  _+  0.5  0.81  -+ 0.2  6.37  _+  0.6 
* Intravenously rejected 3.2-5.9  ×  105 cpm (107 cells) into 950  R T-irradiated LAFI mice (four to 
five per group). 
* Cells incubated for 2 h at 37°C at a concentration of 107/ml with VSV at a  concentration of 2.5  x 
10  s PFU/ml. 
§ cpm expressed as % of injected cpm/10 ml blood 
II Mean  _+  SE. 
labeled with 51Cr and, after washing, a portion of these labeled cells was further 
incubated with VSV (moi 25) as usual.  After washing, the cells were intrave- 
nously injected and organs were removed 1 and 3 days later. VSV pretreatment 
did  not cause  any  reduction  in  the  amount  of T-radioactivity  present  in  the 
spleen at either time after cell injection  (Table IV).  It should be noted that a 
decrease  of as  much  as  12%  (24),  which  is  the  percentage  of parental  cells 
estimated to respond against F1 hybrids in the rat and which would have been 
destroyed by VSV which infects responding cells, would not be detected in this 
type of experiment. 
Discussion 
The present results demonstrate that VSV infection under appropriate condi- 
tions is capable of inhibiting  the proliferative phase  of the  GVH response in 
mice.  Further,  they confirm previous observations made in vitro  (3,  16) that 
VSV affects primarily T lymphocytes, and indicate that cells preinfected in vitro 
are killed by the virus when they are activated against alloantigens in vivo. The 
relative resistance of non-T-cell responses and of hematopoietic cells is borne out 
by the lack of inhibitory effect of VSV on their proliferation. The B-cell nature of 
the resistant recruited cell was established in previous work (19). It is interest- 
ing to note, however, that the inhibition  of the T-cell response by VSV in the 
present studies included an abolition of the recruiting  ability of these cells as 
well.  This  might  have  been  expected  in  view of the  fact  that  VSV  rapidly 
inhibits  host  cell  macromolecular  synthesis  upon activation  (25-27)  and  this 
would prevent production of a factor responsible for the recruitment of B cells. 
No such inhibition is seen when T cells are inhibited merely from proliferating 
by mitomycin treatment and can also induce delayed hypersensitivity reactions 
(28). In vivo injection of VSV or in vitro treatment by VSV before injection of T 
cells appears to lead to a  total abolition of both T-cell proliferation and T-cell- 
induced responses. 
It is of obvious interest to attempt to apply this information to the prevention 
or treatment of secondary disease in vivo caused by allogeneic or semiallogeneic 672  VIRAL  IMMUNOSUPPRESSION  OF  THE  GRAFT-VS.-HOST  REACTION 
spleen or bone marrow transplants in irradiated hosts. While preinfection with 
VSV  can  abrogate the  reactivity of T  cells,  the  obvious consequence in the 
immunologically compromised host would be a  viremia and possibly viral dis- 
ease. Thus development of this strategy for treatment of humans would require 
protection of the host against the consequences of virus infection. Two possibili- 
ties  for  avoiding this  complication are  envisioned.  First,  the  host  could  be 
protected against VSV by treatment with anti-VSV serum.  Preliminary find- 
ings  (to be  published)  suggest that  suppression  of spleen-induced secondary 
disease can indeed be effected by prior incubation of the parental spleen cells 
with VSV,  and that the recipients survive if they are protected from dissemi- 
nated virus infection by treatment with anti-VSV antibody. The present results 
with anti-VSV antibody incubation before injection of VSV-infected cells also 
suggest that virus had been adsorbed and penetrated into the T cells and could 
no longer be inhibited from exercising its lytic effect on these cells by anti-VSV. 
A second possibility would be to employ temperature-sensitive mutants of the 
virus which would be capable of killing the T cells at a nonpermissive tempera- 
ture  (37°C) without producing infectious virus,  as  appears  to be the case  for 
certain tissue culture cells (29). Preliminary data indicate this to be possible 
with at least two ts mutants of  VSV in human lymphocytes (to be published). 
In in vitro studies on suppression of mixed lymphocyte cultures it has become 
clear that not all preparations  of VSV  are  effective in establishing latent or 
persistent infections in lymphocytes. Preliminary evidence suggests that defec- 
tive interfering virus particles may play an important role. It will be important, 
therefore, to establish the optimal conditions for infecting normal lymphocytes 
to achieve maximal selective immunosuppression upon later stimulation. 
Woodruff  and Woodruff  found that Newcastle disease virus (NDV), another T- 
cell specific virus (12), inhibited skin graft rejection in mice (30) but the effect 
was only transient in spite of daily injections of virus. These authors suggested 
that the effect might be caused by a change in surface structure of the lympho- 
cytes which temporarily altered their normal migration pattern in the host (23, 
31). It is also possible that during the course of skin graft rejection the recipients 
produced antibodies ~o  the virus  and neutralized its  effects.  2 In the  present 
studies, VSV-infected cells showed an undiminished tendency to accumulate in 
the spleens of host mice although their proliferation was inhibited. Similarly 
McFarland (4) has found that infection of mice with measles virus selectively 
inhibits the T-cell helper response, thus reinforcing the impression that selec- 
tive T-cell responses may be abrogated by certain viral infections in vivo. 
There remain a  number of problems to be explored in this model. It will be 
important to establish the degree to which B-cell function is restored in the 
recipients, particularly in terms of thymus-dependent and thymus-independent 
antibody responses.  Similarly, it will be of interest to ascertain the degree to 
2  A recent paper by McGregor et al  (J  Exp  Med.  144:627, 1976) has appeared m which it is 
reported that in vitro infection  of sensitized thoracic duct lymphocytes  with NDV blocked their 
ablhty to transfer cellular resistance to L~sterm monocytogenes,  and delayed-type  hypersenmtlvity 
to soluble Llsterla antigens While NDV, m contrast to VSV, may act both by altering the 
migration pattern of the cells, it is hkely that the principal mechanism  of immunosuppresslon  of 
the premfeeted  cells is similar to that descmbed here ROMANO, NOWAKOWSKI, BLOOM, AND  THORBECKE  673 
which T-cell reconstitution of the allogeneic spleen occurs,  and whether any 
helper activity, proliferating activity, or cytotoxic T-lymphocyte activity can be 
developed to unrelated antigens. Finally, the duration of the immunosuppres- 
sion of GVH reactions in animals protected against the effects of infectious virus 
will  be  important to  determine,  in  order  to  learn  whether  this  strategy is 
effective only against acute GVH reactions or may also diminish the chronic 
manifestations as well. 
Summary 
Graft-vs.-host (GVH)  reactivity of parental lymph node (LN) cells was as- 
sayed by measurements of 3H-thymidine incorporation in vivo in  spleens  of 
irradiated  F~  recipients.  Preincubation  of parental  LN  cells  with  vesicular 
stomatitis virus (VSV) for 2 h at 37°C followed by washing resulted in an 85-90% 
reduction in  splenic radioactivity, as  did injection of VSV  on days 0-2  after 
recipients  received  untreated  parental  LN  cells.  In  contrast,  3H-thymidine 
incorporation in the spleens or irradiated F~ hosts was not affected by VSV when 
F~ bone marrow cells were incubated with the virus. In addition, preincubation 
of F1 B cells with VSV still allowed these syngeneic B cells to be recruited into 
proliferation by mitomycin-treated parental LN cells.  The inhibitory effect of 
VSV,  thus,  seems  to  be  specific  for T-cell  proliferation.  These  observations 
suggest that viral immunosuppression might be capable of being developed into 
a  useful  strategy  for  selective  deletion  of lymphocytes capable  of reacting 
against histocompatibility antigens and initiating GVH reactions. 
Received for publication 15 November 1976. 
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